Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

Skinternal Medicine: A Case Based Challenge

Description

In the session called "Skinternal Medicine: A Case Based Challenge," directed by Courtney Shad, the focus was on diagnosing skin diseases linked to internal disorders, along with developing cost-effective evaluation methods and evidence-based management for complex medical dermatological cases. An emergency led to the cancellation of a speaker's presentation, but the session proceeded with interactive audience participation using QR codes for responding to questions. A primary case discussed involved a 29-year-old man with a painful rash, previously diagnosed with psoriasis, who had recently stopped a medication and received a COVID vaccine. Through audience questions, the discussion transitioned into diagnosing IgA vasculitis, with emphasis on the differences in adult and pediatric presentations, as well as the importance of biopsy techniques in confirming the diagnosis. Key points raised included the commonality of renal involvement in adults, the utility of urine analyses, and the lack of benefit from using prednisone in adult patients to prevent nephropathy. Clinical pearls emphasized the necessity of early biopsies, regular kidney function monitoring, and considering potential links between autoimmune disorders and medications. The session concluded with suggestions for ongoing monitoring of kidney function in patients diagnosed with IgA vasculitis, highlighting the significance of early detection and comprehensive management to mitigate serious health complications.

View more

Conclusions

  • Adults with IgA vasculitis (IgAV) have a higher risk of renal involvement compared to children.
  • Normal serum creatinine does not rule out kidney disease in patients with IgAV; a urinalysis should be performed.
  • Dapsone is the first line treatment for IgAV in adults to manage the condition, while prednisone does not prevent nephropathy.
  • In adults, the incidence of developing renal insufficiency due to IgAV can be as high as 30 to 50%.
  • Regular monitoring of kidney function is necessary for adults with IgAV, especially for those presenting with early symptoms.
  • Patients on adalimumab may be at risk for developing IgAV, suggesting a potential link between the medication and vasculitis.
  • Vaccination can possibly trigger IgA vasculitis, although the evidence is primarily based on case reports.
  • Xie F, et al. J Cutan Pathol 2023;50(7):681-686
  • Gardner-Medwin JM, et al. Lancet 2002;360(9341):1197
  • Dolezalova P, et al. J Rheumatol 2004;31(11):2295
  • Yang YH, et al. Rheumatology 2005;44(5):618
  • Hocevar A, et al. Br J Dermatol 2014;171(3):524
  • Piram M, et al. Pediatrics 2018;142(5)
  • Urushikubo J, et al. Clin J Gastroenterol 2021;14(1):198
  • Perkovic D, et al. Clin Rheumatol 2021;40(5):2071
  • Dudley J, et al. Arch Dis Child 2013;98(10):756-63
  • Pillebout E, et al. J Am Soc Nephrol 2002;13(5):1271
  • Calvino MC, et al. Medicine (Baltimore) 2001;80(5):279
  • Trygstad CW, Steihm ER. Pediatrics 1971;47(6):1023
  • Davin JC, et al. Kidney Int 2001;59(3):823
  • Johnson EF, et al. Br J Dermatol 2015;172(5):1358-63
  • Chan H, et al. PLoS One 2016;11(11):e0167346
  • Wei SS, Sinniah R. Case Rep Nephrol 2013;2013:812781. doi: 10.1155/2013/812781. Epub 2013 Jul 24.
  • Alsulami S, et al. Cureus. 2022 Oct 10;14(10):e30122. doi: 10.7759/cureus.30122. eCollection 2022 Oct.
  • Park SJ, Shin JI. J Crohns Colitis. 2013 Aug;7(7):600. doi: 10.1016/j.crohns.2012.12.005. Epub 2013 Jan 12.
  • Condamina M, et al. J Crohns Colitis. 2020 May 21;14(4):538-542. doi: 10.1093/ecco-jcc/jjz164.
  • Marques I, et al. J Crohns Colitis. 2012 Aug;6(7):796-9. doi: 10.1016/j.crohns.2012.02.019. Epub 2012 Mar 21.
  • van der Houwen TB, et al. Rheumatology (Oxford). 2017 Jan;56(1):134-144. doi: 10.1093/rheumatology/kew366. Epub 2016 Oct 15.